Mikhail Doubrovin

Columbia University — United States

Biochemistry, Genetics and Molecular Biology · Life Sciences

29h-index4.4kcitations139works0.82yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Virus-based gene therapy research(41), Genomics, phytochemicals, and oxidative stress(24), Cancer Research and Treatments(23), bioluminescence and chemiluminescence research(18), CAR-T cell therapy research(16)

Publications139 total

Imaging Microtubule Dynamics In Vivo in Human Brain: Optimal Quantification Based on a Test–Retest Study
Journal of Nuclear Medicine·2026
Clinical Utility of [F18]-Fluciclovine PET/MRI for Differentiating True Progression from Treatment-Related Changes in Patients with Glioblastoma
American Journal of Neuroradiology·2025Open Access
IMG-63. Clinical Utility of 18F-FLUCICLOVINE PET/MRI for Differentiating True Progression from Treatment Effects in Glioblastoma
Neuro-Oncology·2025Open Access
Comparing Whole-Body Diffusion-weighted MRI to Conventional Imaging: Staging Pediatric Bone and Soft-Tissue Sarcomas
Radiology Imaging Cancer·2025· 2 citedOpen Access
Data from Immuno-PET Monitoring of Lymphocytes Using the CD8-Specific Antibody REGN5054
2023Open Access
Data from Immuno-PET Monitoring of Lymphocytes Using the CD8-Specific Antibody REGN5054
2023Open Access
Supplementary Data from Immuno-PET Monitoring of Lymphocytes Using the CD8-Specific Antibody REGN5054
2023Open Access
Supplementary Data from Immuno-PET Monitoring of Lymphocytes Using the CD8-Specific Antibody REGN5054
2023Open Access
Abstract 2810: Increasing the efficacy of KRASG12Cinhibitor therapy through the adjuvant use of FAP targeted radiotherapy in a murine model of lung cancer
Cancer Research·2023
Supplementary Figure 2 from Characterization of a c-Rel Inhibitor That Mediates Anticancer Properties in Hematologic Malignancies by Blocking NF-κB–Controlled Oxidative Stress Responses
2023Open Access
Supplementary Figure 5 from Characterization of a c-Rel Inhibitor That Mediates Anticancer Properties in Hematologic Malignancies by Blocking NF-κB–Controlled Oxidative Stress Responses
2023Open Access
Data from Characterization of a c-Rel Inhibitor That Mediates Anticancer Properties in Hematologic Malignancies by Blocking NF-κB–Controlled Oxidative Stress Responses
2023Open Access
Supplementary Figure 3 from Characterization of a c-Rel Inhibitor That Mediates Anticancer Properties in Hematologic Malignancies by Blocking NF-κB–Controlled Oxidative Stress Responses
2023Open Access
Supplementary Figure 3 from Characterization of a c-Rel Inhibitor That Mediates Anticancer Properties in Hematologic Malignancies by Blocking NF-κB–Controlled Oxidative Stress Responses
2023Open Access
Supplementary Figure 2 from Imaging Transgene Activity <i>In vivo</i>
2023Open Access
Supplementary Figure 7 from Characterization of a c-Rel Inhibitor That Mediates Anticancer Properties in Hematologic Malignancies by Blocking NF-κB–Controlled Oxidative Stress Responses
2023Open Access
Supplementary Figure 6 from Characterization of a c-Rel Inhibitor That Mediates Anticancer Properties in Hematologic Malignancies by Blocking NF-κB–Controlled Oxidative Stress Responses
2023Open Access
Supplementary Figure 1 from Characterization of a c-Rel Inhibitor That Mediates Anticancer Properties in Hematologic Malignancies by Blocking NF-κB–Controlled Oxidative Stress Responses
2023Open Access
Supplementary Figure 8 from Characterization of a c-Rel Inhibitor That Mediates Anticancer Properties in Hematologic Malignancies by Blocking NF-κB–Controlled Oxidative Stress Responses
2023Open Access
Supplementary Figure Legends 1-4 from Imaging Transgene Activity <i>In vivo</i>
2023Open Access
page 1 of 7Next →

Frequent Co-authors

Ronald G. Blasberg(27), Juri G. Gelovani(24), Julius Balatoni(19), Vladimir Ponomarev(15), Tatiana Beresten(15), Inna Serganova(13), Ludmila Ageyeva(9), Ronald D. Finn(8), Steven M. Larson(8), Ekaterina Doubrovina(7), Richard J. O’Reilly(7), William G. Bornmann(7), Ronald Finn(6), Michel Sadelain(6), Philipp Mayer‐Kuckuk(6), Jelena Vider(5), Pat Zanzonico(5), Jason A. Koutcher(5), Akiva Mintz(5), Timothy Akhurst(4)